StockWatch
·
Pharmaceuticals
Insider Trading7 May 2026, 08:01 pm

Alivus Life Sciences: Trading Window Closure (Apr 1-May 16, 2026)

AI Summary

Alivus Life Sciences Ltd. announced the closure of its trading window from April 1, 2026, to May 16, 2026, for designated persons. This closure is in anticipation of the Board of Directors meeting on May 14, 2026, to approve the audited financial results for the quarter and year ended March 31, 2026, and to consider recommending a dividend on equity shares.

Key Highlights

  • Trading window closed from April 1 to May 16, 2026.
  • Board meeting scheduled for May 14, 2026, to approve financial results.
  • Consideration of dividend on equity shares for FY26.
  • Closure is for designated persons as per insider trading regulations.